Immyfounded In 1979Is A Global Leader In Developing Diagnostic Solutions For Infectious Diseasesparticularly Fungal Infectionsthe Company Operates In Over 80 Countriesfocusing On Reducing The Global Burden Of Fungal Diseases That Impact Over 1 Billion Peopleimmy Emphasizes Accurate And Rapid Diagnostics To Improve Patient Outcomes And Combat Antimicrobial Resistance The Company Offers A Range Of Diagnostic Tests And Reagentsincluding Rapid Lateral Flow Assays For Quick Results And Enzyme Immunoassays For High Volume Testingtheir Products Are Essential For Diagnosing Conditions Like Cryptococcal Meningitis In Hiv Aids Patientsimmy Also Provides A Saas Healthcare Platform Through Its Immy Technology Groupwhich Includes Customizable Modules And Cloud Based Solutionstheir Expert Support Team Assists With Infrastructure Optimization And Security Immy Serves Clinicianslaboratoriansand Infectious Disease Physicians Worldwidewith A Strong Focus On Hiv Aids Care Programsespecially In Resource Limited Settingstheir Diagnostics Are Distributed Through Partners And Are Utilized In Hospitalslaboratoriesand Community Health Programs Globally
